SCHEMBL7441183

SCHEMBL7441183

CCN(CC)C(=O)Oc1nc(C)c2cc(OC)c(OC)cc2c1[N+](=O)[O-]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.39
TSPO P30536 5/20 0.37
COMT P21964 1/20 0.37
KDM4E B2RXH2 3/20 0.36
MAPT P10636 2/20 0.36
BLM P54132 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 3/20 0.34
HPGD P15428 1/20 0.34
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
PKM P14618 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
PDE10A Q9Y233 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7440312 0.85 NCEH1 (0.40) LMNAKDM4EMEN1KMT2AALDH1A1
SCHEMBL7437559 0.84 KMT2A (0.41) LMNAKDM4EMAPTBLMTDP1
SCHEMBL7439631 0.83 MAPT (0.40) LMNAKDM4EMAPTBLMTDP1
SCHEMBL7426725 0.82 LMNA (0.43) LMNATSPOKDM4EMAPTMEN1
SCHEMBL7446369 0.81 MEN1 (0.40) LMNAKDM4EMAPTTDP1MEN1
SCHEMBL7428283 0.80 VCP (0.39) LMNAKDM4EMAPTBLMTDP1
SCHEMBL7444737 0.78 PDE3B (0.44) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL7443770 0.77 KMT2A (0.47) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL7414190 0.77 KDM4E (0.39) LMNAKDM4EMAPTBLMTDP1
SCHEMBL7446891 0.76 LMNA (0.41) LMNATSPOKDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4880817-A O-functionalized derivatives of substituted isoquinolin-3-ols having cardiotonic and/or phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-11-14 US disclosed